Market cap $1.67B
Enterprise value $633.09M
Revenue $1.138B
EBITDA $37.200M
Income -$57.90
Revenue Q/Q -7.35%
Revenue Y/Y -2.46%
P/E N/A
Forward P/E 4.61
EV/Sales 0.56
EV/EBITDA 17.02
EV/EBIT N/A
PEG 0.55
Price/Sales 1.47
P/FCF 86.73
Price/Book 1.78
Book/Share 5.61
Cash/Share 0.94
FCF yield 1.15%
Employees 1,697
RPE $670.831k
Volume 913.292k / 346.450k
Relative vol. 2.64 ×
EPS N/A
EPS Q/Q -23.68%
Est. EPS Q/Q -11.11%
Ret. on assets -3.78%
Ret. on equity -6.52%
ROIC 6.28%
ROCE -3.46%
Volatility 6.42%
Beta 1.18
RSI 38.18
Range $9.60 – $10.07
52 weeks $8.54 – $38.05
SMA 50 $11 -14.62%
SMA 200 $16 -65.47%
1 year target $36 +261.08%
Mean Recomm. 2.00
Shares outst. 35.391M
Shares float 0.000 0.00%
Short % of float 2.38%
Short ratio 4.18
1 year target $36 +261.08%
Mean Recomm. 2.00
Dividend $0.56
Dividend yield 5.73%
Payout ratio 35.44%
Payment date 26 Jul 2024
Ex-dividend date 12 Jul 2024
Earnings date 26 Jun 2024
IPO year 1982
Country United States

Recent Methode Electronics news

Tuesday, 21 June 2022
 
duckduckgo
Methode Electronics Has Re-Affirmed Its Dividend Of US$0.14
Monday, 28 March 2022
 
netcials
Investing in Methode Electronics three years ago would have delivered you a 53% gain
Wednesday, 8 December 2021
 
gurufocus
Methode Electronics Inc COO Joseph Elias Khoury Sold $909,000 of Shares
Thursday, 24 June 2021
 
yahoo
Methode Electronics, Inc. Reports Fiscal 2021 Fourth Quarter and Full Year Financial Results - Yahoo Finance
Wednesday, 2 June 2021
 
yahoo
Methode Electronics to Present at the Stifel 2021 Virtual Cross Sector Insight Conference - Yahoo Finance
Thursday, 4 March 2021
 
yahoo
Methode Electronics, Inc. to Host Earnings Call - Yahoo Finance
Monday, 28 September 2020
 
prnewswire
Alligator Bioscience appoints Gayle Mills as Chief Business Officer
Wednesday, 16 September 2020
 
prnewswire
Alligator Bioscience receives patent approval for the drug candidate ATOR-1015
Wednesday, 9 September 2020
 
prnewswire
Alligator Bioscience presents an update regarding the Phase I study with the drug candidate ATOR-1015
Friday, 4 September 2020
 
prnewswire
Alligator Bioscience presents positive biomarker data demonstrating proof of mechanism in mitazalimab clinical Phase I study
Thursday, 27 August 2020
 
prnewswire
Alligator Bioscience: Encouraging interim safety data in ATOR-1017 clinical Phase I study
Tuesday, 25 August 2020
 
prnewswire
Alligator Bioscience Virtual R&D Day - August 27, 2020
prnewswire
Alligator Bioscience presents the clinical project portfolio at Virtual R&D Day August 27, 2020
Monday, 13 July 2020
 
prnewswire
Alligator Bioscience AB Interim Report January-June 2020
Tuesday, 30 June 2020
 
yahoo
Were Hedge Funds Right About Selling Methode Electronics Inc. ?
zacks
Methode Q4 Earnings and Revenues Miss Estimates
Monday, 22 June 2020
 
yahoo
Cohen & Steers MLP Income and Energy Opportunity Fund Announces Share Repurchases
Monday, 15 June 2020
 
prnewswire
Alligator Bioscience Appoints New CFO
Thursday, 4 June 2020
 
prnewswire
Alligator Bioscience and Scandion Oncology Sign Preclinical Agreement to Explore Combination Therapies for Chemotherapy and Immuno-oncology
Monday, 1 June 2020
 
prnewswire
Alligator Bioscience's Collaboration With Biotheus Inc. Proceeds and Second Payment is Received
Friday, 29 May 2020
 
yahoo
Alligator Bioscience Presents Novel Supportive Phase I Data at ASCO for its CTLA-4 x OX40 Bispecific Drug Candidate ATOR-1015
Monday, 25 May 2020
 
yahoo
Volatility 101: Should Methode Electronics Shares Have Dropped 37%?
Sunday, 12 April 2020
 
simplywall.st
Why You Might Be Interested In Methode Electronics, Inc. For Its Upcoming Dividend
Friday, 10 April 2020
 
yahoo
Should Value Investors Buy Methode Stock?
Thursday, 26 March 2020
 
yahoo
How Should Investors React To Methode Electronics, Inc.'s CEO Pay?
Friday, 6 March 2020
 
zacks
Methode Electronics Up on Q3 Earnings and Revenue Beat
zacks
Company News for Mar 6, 2020
Monday, 3 February 2020
 
zacks
Methode Electronics Enters Oversold Territory
Tuesday, 28 January 2020
 
yahoo
Does Methode Electronics, Inc. Have A High Beta?
Friday, 10 January 2020
 
yahoo
Are Investors Undervaluing Methode Electronics, Inc. By 36%?
Monday, 23 December 2019
 
yahoo
Do You Know What Methode Electronics, Inc.'s P/E Ratio Means?
Friday, 6 December 2019
 
yahoo
Edited Transcript of MEI earnings conference call or presentation 5-Dec-19 4:00pm GMT
Thursday, 5 December 2019
 
yahoo
Methode Electronics, Inc. Vies For A Place In Your Dividend Portfolio: Here's Why
zacks
Methode Tops Q2 Earnings Estimates
Monday, 28 October 2019
 
yahoo
Did Hedge Funds Drop The Ball On Methode Electronics Inc. ?
Monday, 21 October 2019
 
yahoo
Why Methode Electronics, Inc. Could Be Worth Watching
Saturday, 5 October 2019
 
yahoo
Here's What We Like About Methode Electronics, Inc. 's Upcoming Dividend
Wednesday, 2 October 2019
 
yahoo
Is Methode Electronics, Inc.'s CEO Paid At A Competitive Rate?
Wednesday, 25 September 2019
 
zacks
Should Value Investors Pick Methode Electronics Stock?
Thursday, 29 August 2019
 
yahoo
Edited Transcript of MEI earnings conference call or presentation 29-Aug-19 3:00pm GMT
gurufocus
Methode Electronics Rallies on Earnings and Revenue Surprise
Friday, 16 August 2019
 
yahoo
Does The Methode Electronics, Inc. Share Price Tend To Follow The Market?
Friday, 5 July 2019
 
insidermonkey
Here’s What Hedge Funds Think About Methode Electronics Inc.
yahoo
Methode Electronics, Inc. : Are Analysts Bullish?
Friday, 21 June 2019
 
yahoo
Read This Before You Buy Methode Electronics, Inc. Because Of Its P/E Ratio
Thursday, 20 June 2019
 
fool
Methode Electronics Inc. Q4 2019 Earnings Call Transcript
benzinga
Methode Electronics Shares Fall After Q4 Earnings Miss
Thursday, 6 June 2019
 
yahoo
Why Dividend Hunters Love Methode Electronics, Inc.
Wednesday, 1 May 2019
 
yahoo
Should You Be Holding Methode Electronics, Inc. ?
Friday, 12 April 2019
 
yahoo
How Do Analysts See Methode Electronics, Inc. Performing In The Next 12 Months?
Thursday, 11 April 2019
 
yahoo
Is Methode Electronics Stock Outpacing Its Computer and Technology Peers This Year?
8-K 7 May 2024 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compens...
8-K 8 Apr 2024 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compens...
10-Q 7 Mar 2024 Quarterly report
8-K 7 Mar 2024 Entry into a Material Definitive Agreement; Results of Operations and Financial Condition; Creation of a Di...
8-K 19 Dec 2023 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compens...
10-Q 7 Dec 2023 Quarterly report
8-K 7 Dec 2023 Results of Operations and Financial Condition; Departure of Directors or Certain Officers; Election of Dire...
8-K 18 Sep 2023 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compens...
8-K 7 Sep 2023 Results of Operations and Financial Condition; Financial Statements and Exhibits
10-Q 7 Sep 2023 Quarterly report
8-K 31 Aug 2023 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compens...
Insider
Trans.
Transaction
Price per share Total value
Donald W Duda Chief Executive Officer Buy 21 Sep 2023 $21.80 $506,741
Walter J Aspatore Buy 20 Sep 2023 $22.50 $22,500
Donald W Duda Chief Executive Officer Option 12 Dec 2022 $37.01 $268,174
Lawrence B Skatoff Director Sale 9 Dec 2022 $46.90 $93,800
Brian J Cadwallader Sale 8 Dec 2022 $46.80 $102,960
Donald W Duda Chief Executive Officer Option 7 Dec 2022 $37.01 $1,212,226
Walter J Aspatore Sale 6 Dec 2022 $48.67 $438,030
Darren Dawson Sale 6 Dec 2022 $48.14 $168,490
Joseph Elias Khoury Chief Operating Officer Sale 19 Sep 2022 $38.50 $462,000
Joseph Elias Khoury Chief Operating Officer Sale 28 Jun 2022 $38.55 $308,400
Lawrence B Skatoff Director Sale 17 Dec 2021 $44.89 $35,912
Q2 2022
2 December 2021
Q2 2022 Earnings Call Transcript
Q1 2022
2 September 2021
Q1 2022 Earnings Call Transcript
Q4 2021
24 June 2021
Q4 2021 Earnings Call Transcript
Q3 2021
4 March 2021
Q3 2021 Earnings Call Transcript
Q2 2021
3 December 2020
Q2 2021 Earnings Call Transcript
Q1 2021
3 September 2020
Q1 2021 Earnings Call Transcript
Q4 2020
30 June 2020
Q4 2020 Earnings Call Transcript
Q3 2020
5 March 2020
Q3 2020 Earnings Call Transcript
Q2 2020
5 December 2019
Q2 2020 Earnings Call Transcript
Q1 2020
29 August 2019
CEO Don Duda on Q1 2020 Results - Earnings Call Transcript
Q1 2020
29 August 2019
Q1 2020 Earnings Call Transcript

151 people own Methode Electronics on Robinhood

Powered by Robintrack.

Overall analyst rating

Price target

Current $9.97
Average $36.00
Low $34 High $38

Dividends

Ex-dividend date 12 Jul 2024 Frequency Quarterly Annual dividend +0.00%
Next dividend 26 Jul 2024 Dividend yield 5.73% Growth period 3 years
Last dividend date Yield 3 years 3.15% Growth 3 years +8.37%
Last dividend Yield 5 years 2.32% Growth 5 years +4.94%

Methode Electronics dividend history

Methode Electronics executives

Insider Age Since Compensation
Donald W. Duda (66) Pres, CEO, and Director 66 $2,726,554
Donald Duda (64) President, Chief Executive Officer, and Director since 2004 64 2004 $1,515,120
Andrea Barry (57) Chief Human Resource Officer since 2017 57 2017 $1,410,510
Joseph E. Khoury (57) Chief Operating Officer 57 $1,270,734
Ronald L.G. Tsoumas (60) VP of Corp. Fin. and CFO 60 $1,002,894
Kevin Michael Martin $837,353
Joseph Khoury (56) Chief Operating Officer and Senior Vice President since 2018 56 2018 $711,754
Andrea Jean Barry (58) Exec. VP and Chief HR Officer 58 $708,378
Anil Shetty (54) Vice President, General Manager - Asia, and President - Dabir since 2018 54 2018 $652,194
Ronald Tsoumas (59) Chief Financial Officer since 2018 59 2018 $630,058
Timothy Glandon (56) Vice President since 2015 56 2015 $326,455
Walter Aspatore (77) Independent Chairman of the Board since 2012 77 2012 $194,780
Darren Dawson (57) Independent Director since 2004 57 2004 $175,530
Lawrence Skatoff (80) Independent Director since 2004 80 2004 $159,280
Brian Cadwallader (61) Independent Director since 2018 61 2018 $159,280
Bruce Crowther (68) Independent Director since 2019 68 2019 $142,030
Mark Schwabero (67) Independent Director since 2019 67 2019 $129,280
David Blom (66) Independent Director since 2019 66 2019 $20,500
Angelo Pantaleo (60) Independent Director since 2019 60 2019 $18,500
Mary Lindsey (64) Independent Director since 2020 64 2020 $11,000
Therese Bobek (59) Independent Director since 2020 59 2020 $11,000
Robert Cherry 2020
Anil V. Shetty (55) VP, Pres of Dabir Surfaces, and Inc. 55
Mark Shermetaro
Kristine Walczak
Amit N. Patel
Company Market cap P/E EV/EBITDA P/S P/B P/FCF Change
$1.67B N/A 17.02 1.47 1.78 86.73 +2.05%
$70.44B N/A N/A 2.16 14.65 14.69 +0.24%
$46.74B 41.02 27.03 3.64 5.60 20.96 +0.98%
$38.87B 13.65 13.60 2.46 3.37 14.55 +0.67%
$632.34M N/A 14.08 0.65 2.20 N/A -0.69%
$57.87M N/A N/A 0.28 0.27 N/A -1.28%
$52.30M 0.00 N/A 0.86 1.32 34.73 -0.88%
$31.10M 0.00 N/A 0.48 1.26 45.19 -1.43%

methode electronics, inc. (nyse: mei) is an international engineering company headquartered in chicago, il. methode was founded in 1946 as a single-product manufacturer and has since expanded its business into industrial design, distribution and professional services. here at methode, we utilize technical capabilities to develop custom-engineered application-specific products and solutions for a variety of markets and customers. this includes the industries of automotive, big data, white goods, aerospace & defense, consumer electronics and healthcare. for additional information, visit methode.com.

  • Technology > Electronic Components
  • Methode Electronics, Inc., 8750 West Bryn Mawr Avenue, Chicago 60631-3518, United States
  • 708 867 6777
  • Investor relations

Dividends

Ex-dividend date 12 Jul 2024 Frequency Quarterly Annual dividend +0.00%
Next dividend 26 Jul 2024 Dividend yield 5.73% Growth period 3 years
Last dividend date Yield 3 years 3.15% Growth 3 years +8.37%
Last dividend Yield 5 years 2.32% Growth 5 years +4.94%

Methode Electronics dividend history

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

(in millions USD) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $122.9 $122.5 $147.9 $157
Short term investments
Net receivables $265.3 $292.3 $300.8 $314.3
Inventory $204 $183.9 $175.6 $159.7
Total current assets $629.8 $636.5 $657.5 $664.4
Long term investments
Property, plant & equipment $258.4 $251.5 $254.7 $248.7
Goodwill & intangible assets $484.7 $485.4 $553.8 $558.6
Total noncurrent assets $861.7 $848.4 $916.6 $914.7
Total investments
Total assets $1,491.5 $1,484.9 $1,574.1 $1,579.1
Current liabilities
Accounts payable $146 $133.5 $131.9 $138.7
Deferred revenue
Short long term debt $6.5 $9.6 $10.1 $10
Total current liabilities $229.9 $218.3 $208.4 $228
Long term debt $351 $349.9 $358.2 $325.4
Total noncurrent liabilities $426.6 $421.7 $433.4 $398.2
Total debt $357.5 $359.5 $368.3 $335.4
Total liabilities $656.5 $640 $641.8 $626.2
Stockholders' equity
Retained earnings $677.6 $697 $764.8 $772.7
Other stockholder equity -$31.2 -$42.9 -$23.1 -$19
Total stockholder equity $835 $844.9 $931.4 $941.8
(in millions USD) 2023 2022 2021
Current assets
Cash $157 $172 $233.2
Short term investments
Net receivables $314.3 $273.3 $282.5
Inventory $159.7 $158.5 $124.2
Total current assets $664.4 $629 $674
Long term investments
Property, plant & equipment $248.7 $217 $226.3
Goodwill & intangible assets $558.6 $440.7 $465
Total noncurrent assets $914.7 $760.1 $793
Total investments
Total assets $1,579.1 $1,389.1 $1,467
Current liabilities
Accounts payable $138.7 $108.5 $122.9
Deferred revenue
Short long term debt $10 $19 $21
Total current liabilities $228 $188.6 $222.7
Long term debt $325.4 $212.3 $242.7
Total noncurrent liabilities $398.2 $286.7 $326.3
Total debt $335.4 $231.3 $263.7
Total liabilities $626.2 $475.3 $549
Stockholders' equity
Retained earnings $772.7 $763.9 $746
Other stockholder equity -$19 -$26.8 $6.1
Total stockholder equity $941.8 $913.8 $918

Income statement

(in millions USD) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $259.5 $288 $289.7 $301.2
Cost of revenue $222.5 $235.7 $235.7 $237.9
Gross profit $37 $52.3 $54 $63.3
Operating activities
Research & development
Selling, general & administrative $33.9 $40.9 $44.5 $50.1
Total operating expenses $40 $103.6 $50.2 $54.8
Operating income -$3 -$51.3 $3.8 $8.5
Income from continuing operations
EBIT -$5.5 -$51.1 $3.8 $9.2
Income tax expense $1.1 -$0.2 $0.1 -$0.3
Interest expense $5 $4.4 $2.8 $1.4
Net income
Net income -$11.6 -$55.3 $0.9 $8.1
Income (for common shares) -$11.6 -$55.3 $0.9 $8.1
(in millions USD) 2023 2022 2021
Revenue
Total revenue $1,179.6 $1,163.6 $1,088
Cost of revenue $915.5 $898.7 $813.9
Gross profit $264.1 $264.9 $274.1
Operating activities
Research & development
Selling, general & administrative $154.9 $134.1 $126.9
Total operating expenses $173.7 $153.2 $146.2
Operating income $90.4 $111.7 $127.9
Income from continuing operations
EBIT $92.8 $122 $140.1
Income tax expense $13 $16.3 $12.6
Interest expense $2.7 $3.5 $5.2
Net income
Net income $77.1 $102.2 $122.3
Income (for common shares) $77.1 $102.2 $122.3
(in millions USD) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$11.6 -$55.3 $0.9 $8.1
Operating activities
Depreciation $14.9 $14.4 $14 $12.7
Business acquisitions & disposals -$114.6
Stock-based compensation -$2.1 $1.3 $2.6 $2.1
Total cash flows from operations $28.8 -$0.6 -$5.6 $49
Investing activities
Capital expenditures -$16.6 -$10.7 -$13.8 -$11.2
Investments $0.6
Total cash flows from investing -$16.7 -$8.5 -$13.8 -$125.8
Financing activities
Dividends paid -$4.9 -$4.8 -$5.3 -$4.9
Sale and purchase of stock -$3 -$7.8 -$8.5
Net borrowings -$9 $2.7 $31.8 $80.2
Total cash flows from financing -$16.9 -$10.6 $12.5 $66.8
Effect of exchange rate $5.2 -$5.7 -$2.2 $2.3
Change in cash and equivalents $0.4 -$25.4 -$9.1 -$7.7
(in millions USD) 2023 2022 2021
Net income $77.1 $102.2 $122.3
Operating activities
Depreciation $49.5 $52.6 $51.5
Business acquisitions & disposals -$114.6 $0.6 $0.1
Stock-based compensation $11.5 $11.8 $6.8
Total cash flows from operations $132.8 $98.8 $179.8
Investing activities
Capital expenditures -$38.5 -$38 -$24.9
Investments
Total cash flows from investing -$153.1 -$37.4 -$24.8
Financing activities
Dividends paid -$19.8 -$20.4 -$17.4
Sale and purchase of stock -$46.6 -$64 -$5.9
Net borrowings $70.1 -$29.9 -$115.7
Total cash flows from financing $3.2 -$114.6 -$142.9
Effect of exchange rate $2.1 -$8 $3.8
Change in cash and equivalents -$15 -$61.2 $15.9

Recent institutional transactions

Quarter Shareholder Change
Shares owned
Shares
Value (in thousands USD)
2024 Q1 Ameriprise Financial Inc
+200.60%
597,498 $7,277,526
2024 Q1 Bnp Paribas Financial Markets
+222.59%
220,932 $2,690,952
2024 Q1 Bridge City Capital
+88.85%
245,640 $2,991,895
2024 Q1 Comerica Bank
-79.94%
15,238 $185,599
2024 Q1 Strs Ohio
+481.43%
40,700 $495
2024 Q1 Legato Capital Management
+51.57%
65,307 $795,439
2024 Q1 Bank Of New York Mellon Corp
+4.70%
483,175 $5,885,078
2024 Q1 New York State Common Retirement Fund
+37.78%
77,908 $949
2024 Q1 Quantbot Technologies L.P.
+44.87%
53,341 $649,693
2024 Q1 Davidson Investment Advisors
Opened
15,800 $192,444

Institutional shareholders

Shareholder Stake
Shares owned
Shares
Value (in thousands USD)
Investment Counselors Of Maryland 3.39% 1,197,985
Geode Capital Management 2.13% 752,645
Ameriprise Financial Inc 1.69% 597,498
Bank Of New York Mellon Corp 1.37% 483,175
Bridge City Capital 0.69% 245,640
Bnp Paribas Financial Markets 0.62% 220,932
Loomis Sayles & Co L P 0.50% 177,565
Parametric Portfolio Associates 0.46% 162,090
Lsv Asset Management 0.30% 104,635
New York State Common Retirement Fund 0.22% 77,908